MAJOR DEPRESSION DISORDER
Clinical trials for MAJOR DEPRESSION DISORDER explained in plain language.
Never miss a new study
Get alerted when new MAJOR DEPRESSION DISORDER trials appear
Sign up with your email to follow new studies for MAJOR DEPRESSION DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Psychedelic DMT studied for depression relief in early human trial
Symptom relief Recruiting nowThis Phase 1 study is testing the safety and brain effects of DMT, a psychedelic drug, in 60 adults with depression and healthy volunteers. Participants receive low or medium doses of DMT, THC, or a placebo, and researchers monitor mood, anxiety, and brain activity. The goal is t…
Matched conditions: MAJOR DEPRESSION DISORDER
Phase: PHASE1 • Sponsor: Deepak C. D'Souza • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could a headset at home lift depression? new trial investigates
Symptom relief Recruiting nowThis study compares the safety and effectiveness of using a mild electrical brain stimulation device (tDCS) at home versus at a clinic for treating major depression. About 198 adults with moderate to severe depression will use the device daily for a few weeks. Researchers will me…
Matched conditions: MAJOR DEPRESSION DISORDER
Phase: NA • Sponsor: Ionclinics & Deionic SL • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Could a light beam lift depression when drugs fail?
Symptom relief Recruiting nowThis study tests a non-invasive light therapy called transcranial photobiomodulation (tPBM) on the forehead to help people with treatment-resistant depression. About 40 adults who still have moderate-to-severe depression despite taking antidepressants will receive tPBM at differe…
Matched conditions: MAJOR DEPRESSION DISORDER
Phase: NA • Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
Which ketamine works better for severe depression? a 5-Year study aims to find out
Knowledge-focused Recruiting nowThis study follows 450 people with treatment-resistant depression who are starting or continuing treatment with either IV ketamine or Spravato (esketamine) nasal spray. Over five years, researchers will track how satisfied patients are with their treatment, how well it works, and…
Matched conditions: MAJOR DEPRESSION DISORDER
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC